Roche has launched the cobas Plasma Separation Card, a stable and easy-to-use sample collection device for HIV plasma viral load testing. By providing a small amount of a patient’s blood from a fingertip, this specially designed card simplifies blood collection and sample transportation. Traditionally, plasma viral load results required blood samples to be cooled during transport to the lab. The new cobas Plasma Separation Card fundamentally changes the way plasma samples are taken and processed. The card allows for reliable quantitative testing of patients with HIV living in remote areas – even areas of extreme heat and humidity – while meeting WHO requirements for determining HIV viral load prior to setting treatment.
With the launch of the cobas Plasma Separation Card, Roche strengthened its ongoing commitment to providing life-saving diagnostics in the fight against HIV and AIDS. This card will improve access and increase HIV diagnostics scaling up efforts to further the critical work of their many healthcare partners in eradicating the HIV/AIDS epidemic. Coupled with the successful Global Access Program, this will make a significant contribution to extending both the reach and accuracy of HIV viral load testing for underserved populations.
The cobas Plasma Separation Card will be added to the Roche Global Access Program as a solution to help expand access to diagnostics in countries hardest hit by HIV. In partnership with the Joint United Nations Program on HIV/AIDS (UNAIDS), the Clinton Health Access Initiative (CHAI), Unitaid, the US President’s Emergency Plan For AIDS Relief (PEPFAR) and the Global Fund to fight AIDS, TB, and Malaria, Roche has been working to increase access to HIV diagnostic solutions to achieve the UNAIDS 90–90–90 goal to improve people knowing their status, getting on HIV therapy, and suppressing the virus from replicating.